Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;9(3):839-846.
doi: 10.21037/tlcr.2019.12.30.

Controversies and challenges in the histologic subtyping of lung adenocarcinoma

Affiliations
Review

Controversies and challenges in the histologic subtyping of lung adenocarcinoma

Kelly J Butnor. Transl Lung Cancer Res. 2020 Jun.

Abstract

Lung adenocarcinomas differ in prognosis based on their histologic growth pattern. Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) both have an excellent prognosis when completely resected, whereas solid and micropapillary-predominant adenocarcinomas do not, with other patterns falling in between. In recent years, it has become apparent that even within histologic patterns, there are differences in appearance that are clinically important, such as complex acinar formations and highly variable-sized papillae. This review highlights prognostically important histologic features in lung adenocarcinoma that have emerged since implementation of the current World Health Organization (WHO) classification of lung adenocarcinoma.

Keywords: Lung adenocarcinoma; classification; histologic; pathology; subtyping.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr.2019.12.30). The series “Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting” was commissioned by the editorial office without any sponsorship or funding. The author has no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Pulmonary AIS, which is defined by pure lepidic growth of neoplastic pneumocytes along alveolar septa (A), may exhibit sclerosis/stromal collapse of the alveolar framework that can be mistaken for invasion (B) (HE stain, ×200). AIS, adenocarcinoma in situ.
Figure 2
Figure 2
Elastic stains can sometimes aid in the distinction between pulmonary AIS and MIA by highlighting breaks (arrows) in the alveolar elastic framework in MIA (Verhoeff-Van Gieson elastin stain, ×200). AIS, adenocarcinoma in situ; MIS, minimally invasive adenocarcinoma.
Figure 3
Figure 3
Lung adenocarcinomas in which complex acinar formations (B) or cribriform arrangements (C) predominate have a worse prognosis that tumors composed predominantly of simple acinar structures (A) (HE stain, ×400).
Figure 4
Figure 4
The degree of atypia and architectural complexity in papillary lung adenocarcinoma can vary considerably, ranging from slightly atypical cells and “pseudolepidic” papillae (A, ×200) to medium-sized papillary thyroid carcinoma-like papillae (B, ×400) to complex papillae with marked atypia (C, ×400) (HE stain).
Figure 5
Figure 5
The micropapillary pattern in lung adenocarcinoma includes a variety of appearances, ranging from the classic form in which tumor cells lacking fibrovascular cores are arranged in papillary tufts, florets, and intraalveolar clusters (A) to the filigree form with its delicate lacelike narrow stacks of tumor cells (B) and the stromal form featuring infiltrating clusters of tumor cells within cleft-like spaces surrounded by stroma (not shown) (HE stain, ×400).
Figure 6
Figure 6
Based on data that have emerged since the current lung adenocarcinoma classification was introduced, some patterns will likely need to be regrouped in future moderations to better align with their risk of recurrence.

References

    1. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85. 10.1097/JTO.0b013e318206a221 - DOI - PMC - PubMed
    1. Travis WD, Brambilla E, Burke AP, et al. editors. WHO classification of Tumours of Lung Pleura, Thymus and Heart. 4th ed. Lyon: IARC, 2015. - PubMed
    1. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64. 10.1038/modpathol.2010.232 - DOI - PubMed
    1. Boland JM, Froemming AT, Wampfler JA, et al. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma-analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules. Hum Pathol 2016;51:41-50. 10.1016/j.humpath.2015.12.010 - DOI - PubMed
    1. Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 2012;25:1574-83. 10.1038/modpathol.2012.106 - DOI - PMC - PubMed